Systemic Mastocytosis — Trials

Systemic Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04333108	Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment	unknown	Phase 3	140	AB ScienceINDUSTRY	8	May 6, 2023	clinicaltrials
NCT01602939	Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis	unknown	Phase 2 / Phase 3	10	Hospital Virgen de la SaludOTHER	1	Aug 29, 2016	clinicaltrials